Welcome to our dedicated page for ZIMVIE news (Ticker: ZIMV), a resource for investors and traders seeking the latest updates and insights on ZIMVIE stock.
ZimVie Inc (ZIMV) delivers innovative dental and spine solutions through advanced biomaterials and digital workflow integration. This news hub provides investors and medical professionals with centralized access to official updates spanning product developments, financial disclosures, and strategic initiatives.
Track announcements across ZimVie's core segments: dental innovations like implant surface technologies and CAD/CAM restorative systems, plus spine surgery advancements in fusion devices and surgical instrumentation. Receive timely updates on regulatory milestones, partnership agreements, and clinical research outcomes.
Our curated news collection enables efficient monitoring of ZimVie's progress in merging digital planning tools with medical device engineering. Discover updates on RealGUIDE® software enhancements, biomaterial research breakthroughs, and market expansion strategies while maintaining compliance with financial disclosure standards.
Bookmark this page for structured access to ZimVie's evolving position in life sciences. Combine technical insights with corporate updates to inform your analysis of this dual-segment medical technology innovator.
ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, has announced that it will report its second quarter 2024 financial results after market close on Thursday, August 1, 2024. The company management will host a conference call at 4:30 p.m. Eastern Time on the same day to discuss the results. Interested parties can register for the call online, with registration recommended more than 15 minutes before the call starts. A replay of the webcast will be available on the company's investor relations website.
On May 16, 2024, ZimVie, a global leader in the dental market, announced its participation in two upcoming investor conferences. The company will present at the Stifel 2024 Jaws & Paws Conference on May 30, 2024, at 11:30 a.m. Eastern Time, and at the 45th Annual Goldman Sachs Global Healthcare Conference on June 12, 2024, at 3:20 p.m. Eastern Time. Interested parties can access a live webcast of these presentations through the 'Investors' section on ZimVie's website.
ZimVie Inc. (Nasdaq: ZIMV) reported third party net sales of $118.2 million, a net loss of ($11.5) million, and an adjusted EBITDA of $12.5 million for the first quarter of 2024. The company completed the sale of its spine business for $375 million, repaid $275 million of debt, and is now focusing on its dental market leadership.
FAQ
What is the current stock price of ZIMVIE (ZIMV)?
What is the market cap of ZIMVIE (ZIMV)?
